Formosa Laboratories, Inc. (TPE:4746)
Taiwan · Delayed Price · Currency is TWD 48.95
+1.25 (2.62%)
Sep 30, 2026, 1:30 PM CST
Formosa Laboratories Market Cap
Formosa Laboratories has a market cap or net worth of 5.74 billion as of September 29, 2026. Its market cap has decreased by -25.82% in one year.
Market Cap
5.74B
Enterprise Value
8.17B
Revenue
4.64B
Ranking
n/a
PE Ratio
12.18
Stock Price
48.95
ChartMarket Cap Chart
Since March 2, 2011, Formosa Laboratories's market cap has increased from 5.60B to 5.74B, an increase of 2.44%. That is a compound annual growth rate of 0.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 5.74B | -19.56% |
| Dec 31, 2025 | 7.13B | -13.81% |
| Dec 31, 2024 | 8.27B | -32.55% |
| Dec 29, 2023 | 12.27B | 38.78% |
| Dec 30, 2022 | 8.84B | 21.49% |
| Dec 30, 2021 | 7.28B | 43.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 10.04B |
| SCI Pharmtech | 6.78B |
| Alar Pharmaceuticals | 6.60B |
| Yoda Pharmaceuticals | 6.00B |
| Orient Pharma | 5.83B |
| LIWANLI Innovation | 4.71B |
| Panion & Bf Biotech | 4.60B |
| Orient EuroPharma | 3.99B |